|
1
|
Bancalari E and Claure N: Bronchopulmonary
dysplasia: Definitions and epidemiology. In: Bronchopulmonary
Dysplasia. Bhandari V: Springer International Publishing.
(Switzerland). 167–182. 2016.
|
|
2
|
Smith VC, Zupancic JA, McCormick MC, Croen
LA, Greene J, Escobar GJ and Richardson DK: Rehospitalization in
the first year of life among infants with bronchopulmonary
dysplasia. J Pediatr. 144:799–803. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhandari A and Panitch H: An update on the
post-NICU discharge management of bronchopulmonary dysplasia. Semin
Perinatol. 42:471–477. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watterberg KL, Demers LM, Scott SM and
Murphy S: Chorioamnionitis and early lung inflammation in infants
in whom bronchopulmonary dysplasia develops. Pediatrics.
97:210–215. 1996.PubMed/NCBI
|
|
5
|
Glaser K and Speer CP: Pre and postnatal
inflammation in the pathogenesis of bronchopulmonary dysplasia. In:
Bronchopulmonary Dysplasia. Bhandari V: Springer International
Publishing. (Switzerland). 55–77. 2016.PubMed/NCBI
|
|
6
|
Gadhia MM, Cutter GR, Abman SH and
Kinsella JP: Effects of early inhaled nitric oxide therapy and
vitamin A supplementation on the risk for bronchopulmonary
dysplasia in premature newborns with respiratory failure. J
Pediatr. 164:744–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lavoie PM: Genetics of bronchopulmonary
dysplasia. In: Bronchopulmonary Dysplasia. Bhandari V: Springer
International Publishing. (Switzerland). 109–127. 2016.PubMed/NCBI
|
|
8
|
Aksamitiene E, Kiyatkin AB and Kholodenko
BN: Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt
pathways: A fine balance. Biochem Soc Trans. 40:139–146. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bernards R: A missing link in
genotype-directed cancer therapy. Cell. 151:465–468. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colaprico A, Cava C, Bertoli G, Bontempi G
and Castiglioni I: Integrative analysis with Monte Carlo
cross-validation reveals miRNAs regulating pathways cross-talk in
aggressive breast cancer. Biomed Res Int. 2015:8313142015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cohen J, Van Marter LJ, Sun Y, Allred E,
Leviton A and Kohane IS: Perturbation of gene expression of the
chromatin remodeling pathway in premature newborns at risk for
bronchopulmonary dysplasia. Genome Biol. 8:R2102007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article32004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bogdan M, Ghosh JK and Tokdar ST: A
comparison of the Benjamini-Hochberg procedure with some Bayesian
rules for multiple testing. In: Beyond Parametrics in
Interdisciplinary Research. Festschrift in Honor of Professor.
Pranab K. Sen.: 1:Institute of Mathematical Statistics. (Beachwood,
OΗ). 211–230. 2008.
|
|
14
|
Routledge R: Fisher's exact test. In:
Encyclopedia of Biostatistics. John Wiley Publishing. (New York,
NY). 2005.
|
|
15
|
Liaw A and Wiener M: Classification and
regression by randomForest. R News. 2:18–22. 2002.
|
|
16
|
Xu QS and Liang YZ: Monte Carlo cross
validation. Chemom Intell Lab Syst. 56:1–11. 2001. View Article : Google Scholar
|
|
17
|
Donato M, Xu Z, Tomoiaga A, Granneman JG,
Mackenzie RG, Bao R, Than NG, Westfall PH, Romero R and Draghici S:
Analysis and correction of cross-talk effects in pathway analysis.
Genome Res. 23:1885–1893. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang H, Cheng C and Zhang W: Average
rank-based score to measure deregulation of molecular pathway gene
sets. PLoS One. 6:e275792011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu QS, Liang YZ and Du YP: Monte Carlo
cross-validation for selecting a model and estimating the
prediction error in multivariate calibration. J Chemometr.
18:112–120. 2004. View
Article : Google Scholar
|
|
20
|
Besnard AG, Sabat R, Dumoutier L, Renauld
JC, Willart M, Lambrecht B, Teixeira MM, Charron S, Fick L, Erard
F, et al: Dual role of IL-22 in allergic airway inflammation and
its cross-talk with IL-17A. Am J Respir Crit Care Med.
183:1153–1163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang SH and Dong C: IL-17F: Regulation,
signaling and function in inflammation. Cytokine. 46:7–11. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin W and Dong C: IL-17 cytokines in
immunity and inflammation. Emerg Microbes Infect. 2:e602013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Puel A, Döffinger R, Natividad A, Chrabieh
M, Barcenas-Morales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon
A, Bustamante J, et al: Autoantibodies against IL-17A, IL-17F, and
IL-22 in patients with chronic mucocutaneous candidiasis and
autoimmune polyendocrine syndrome type I. J Exp Med. 207:291–297.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwakura Y, Nakae S, Saijo S and Ishigame
H: The roles of IL-17A in inflammatory immune responses and host
defense against pathogens. Immunol Rev. 226:57–79. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilson MS, Madala SK, Ramalingam TR,
Gochuico BR, Rosas IO, Cheever AW and Wynn TA: Bleomycin and
IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med.
207:535–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
